1H MRS is utilized in the study to measure metabolic abnormalities in the brains of individuals with presenilin 1 (PS1) and amyloid precursor protein (APP) mutations, who have a nearly 100% risk of developing AD before they show any symptoms. This evidence concerns the gene PSEN1 and Alzheimer disease.